The effects of cannabis products and cannabis derivatives on mental health will be the focus of a new pre-clinical study conducted by Zyus life sciences and the University of Saskatchewan.
Cannabis
CEO Brent Zettl of Zyus life sciences on new partnership with the University of Saskatchewan
More Videos
-
The science behind roadside THC testing and diving into SGI’s zero-tolerance policy
-
Cannabis poisoning concerning for the Sask. Prevention Institute
-
Global News at 6 Saskatoon: Oct. 17
-
A look at cannabis use in Saskatchewan after 5 years of legalization
-
New Saskatoon Police Deputy Chief Cam McBride
-
Saskatchewan Liquor and Gaming Authority exits retail
You are viewing an Accelerated Mobile Webpage.
View Original Article